Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum.

Authors Kay Washington, MD, PhD, FCAP* Department of Pathology, Vanderbilt University Medical Center, Nashville, TN Laura H. Tang, MD, PhD, FCAP† Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY Jordan Berlin, MD Department of Medicine, Vanderbilt University Medical Center, Nashville, TN Philip Branton, MD, FCAP Department of Pathology, Inova Fairfax Hospital, Falls Church, VA Lawrence J. Burgart, MD, FCAP Allina Laboratories, Abbott Northwestern Hospital, Minneapolis, MN David K. Carter, MD, FCAP Department of Pathology, St. Mary’s/Duluth Clinic Health System, Duluth, MN Carolyn C. Compton, MD, PhD, FCAP Critical Path Institute, Tucson, AZ Patrick Fitzgibbons, MD, FCAP Department of Pathology, St. Jude Medical Center, Fullerton, CA Wendy L. Frankel, MD, FCAP Department of Pathology, Ohio State University Medical Center, Columbus, OH John Jessup, MD Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD Sanjay Kakar, MD, FCAP Department of Pathology, University of California San Francisco and the Veterans Affairs Medical Center, San Francisco, CA Bruce Minsky, MD Department of Radiation Oncology, University of Chicago, Chicago, IL Raouf Nakhleh, MD, FCAP Department of Pathology, Mayo Clinic, Jacksonville, FL For the Members of the Cancer Committee, College of American Pathologists